Listed

Fitlife Brands, Inc.: Form 10-Q for the period ended Mar 31, 2013

Filed with the SEC on May 14, 2013 and accepted by EDGAR at May 14, 2013, 16:48 ET.

Share

Management's discussion and analysis

As filed, 10,393 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Statements

Management’s Discussion and Analysis contains various “forward looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding future events or the future financial performance of the Company that involve risks and uncertainties. Certain statements included in this Form 10-Q, including, without limitation, statements related to anticipated cash flow sources and uses, and words including but not limited to “anticipates”, “believes”, “plans”, “expects”, “future” and similar statements or expressions, identify forward looking statements. Any forward-looking statements herein are subject to certain risks and uncertainties in the Company’s business, including but not limited to, reliance on key customers and competition in its markets, market demand, product performance, technological developments, maintenance of relationships with key suppliers, difficulties of hiring or retaining key personnel and any changes in current accounting rules, all of which may be beyond the control of the Company. The Company adopted at management’s discretion, the most conservative recognition of revenue based on the most astringent guidelines of the SEC. Management will elect additional changes to revenue recognition to comply with the most conservative SEC recognition on a forward going accrual basis as the model is replicated with other similar markets. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth therein.

Forward-looking statements involve risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors and risks that could affect our results and achievements and cause them to materially differ from those contained in the forward-looking statements include those identified in the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, as well as other factors that we are currently unable to identify or quantify, but that may exist in the future.

In addition, the foregoing factors may affect generally our business, results of operations and financial position. Forward-looking statements speak only as of the date the statement was made. We do not undertake and specifically decline any obligation to update any forward-looking statements.

Overview

Bond Laboratories, Inc. (the “Company”) is a national provider of innovative and proprietary nutritional supplements for health conscious consumers. The Company produces and markets its products through NDS Nutrition Products, Inc., a Florida corporation (“NDS”). NDS manufactures and distributes a full line of nutritional supplements to support healthy living predominantly through franchisees of General Nutrition Centers, Inc. (“GNC”) located throughout the United States.

The Company was incorporated in the State of Nevada on July 26, 2005. In October 2008, the Company acquired the assets of NDS Nutritional Products, Inc., a Nebraska corporation, and moved those assets into its wholly owned subsidiary NDS.

Bond Laboratories is headquartered in Omaha, Nebraska. For more information on the Company, please go to http://www.bond-labs.com. The Company’s Common Stock currently trades under the symbol BNLB on the OTCQB market.

Results of Operations

Net Sales. Revenue for the three months ended March 31, 2013 increased to $6,061,141 as compared to $4,955,897 for the three months ended March 31, 2012. This increase was primarily driven by continued strong sales of recently introduced products, greater average sales per retail location, and the recent introduction of our products in international markets. We currently market approximately 50 products to over 800 GNC franchise locations nationwide, as well as to eight other countries. The Company continually seeks to increase both the number of stores and number of approved products that comprise its distribution footprint and, while no assurances can be given, anticipates that such efforts will continue to drive future revenue growth. While not a material component of revenue for this quarter, management anticipates that continued international expansion will be a major driver of future growth.

Cost of Goods Sold. Cost of goods sold for the three months ended March 31, 2013 increased to $3,791,233 as compared to $3,208,257 for the three months ended March 31, 2012. The increase was primarily attributable to increased sales volume during the quarter.

General and Administrative Expense. General and administrative expense for the three months ended March 31, 2013 increased to $997,743 as compared to $521,306 for the three months ended March 31, 2012. The increase in general and administrative expense is primarily attributable to the expense recognized in connection with the Company’s issuance of equity to certain employees and advisors for the fair value of services rendered during the quarter ended March 31, 2013. Absent non-cash charges related to stock issued for services, general and administrative expense for the three months ended March 31, 2013 would have increased to $648,073 as compared to $511,145 for the prior comparable quarter. This increase is primarily attributable to higher personnel costs during the current quarter.

Selling and Marketing Expense. Selling and marketing expense for the three months ended March 31, 2013 increased to $610,089 as compared to $443,425 for the three months ended March 31, 2012. The increase in selling and marketing expense is principally attributable to expanded marketing activities designed to support current and expected future revenue growth, which includes costs driven by increased product sales made in connection with the Company’s participation in GNC’s annual franchise convention as well as incremental expense attributable to the Company’s ongoing international expansion. As net sales increase, selling and marketing expense is anticipated to simultaneously increase, although management anticipates that selling and marketing expense will increase at a lower rate.

Depreciation and Amortization. Depreciation and amortization for the three months ended March 31, 2013 decreased to $58,791 as compared to $62,531 for the three months ended March 31, 2012.

Net Income/(Loss). We generated a profit of $587,415 for the three months ended March 31, 2013 as compared to a profit of $719,906 for the three months ended March 31, 2012. The decrease was principally attributable to charges related to the fair value of stock issued for services during the quarter ended March 31, 2013. Excluding such non-cash charges, net income for the quarter ended March 31, 2013 increased 28.4% in connection with 22.3% revenue growth to $937,085 from $730,067. The net increase, while partially offset by higher operating expenses, was driven by greater sales volume and a higher gross margin.

Liquidity and Capital Resources

The Company has historically financed its operations primarily through equity and debt financings, and more recently, cash flow from operations. The Company has also provided for its cash needs by issuing common stock, options and warrants for certain operating costs, including consulting and professional fees. The Company did not engage in any financing activities during the year ended December 31, 2012 or the three month period ended March 31, 2013. Together with anticipated cash derived from operations, our existing cash resources are expected to provide for the Company’s liquidity through at least December 31, 2013. Although no assurances can be given, management currently believes the Company will generate sufficient cash from operations to provide for its working capital needs beyond December 31, 2013.

Cash Provided by/(Used in) Operations. Our cash used in operating activities for the three months ended March 31, 2013 was $(127,540) as compared to cash provided by operating activities of $532,182 for the three months ended March 31, 2012. The decrease is attributable to fluctuations in working capital accounts most notably higher accounts receivable driven by increased sales volume and lower accounts payable net income. Notwithstanding the foregoing, net working capital increased to $5,422,691 as of the quarter ended March 31, 2013 from $4,526,816 as of March 31, 2012. Cash provided by operations during the three months ended March 31, 2013 included $45,000 in payments in connection with the settlement of the Schick Litigation. We anticipate using an additional $60,000 in cash through December 31, 2013 in connection with the settlement of the Schick Litigation; however, management nevertheless anticipates reporting positive cash provided by operations during the quarter ended June 30, 2013, and for the year ended December 31, 2013.

Cash Provided by/(Used in) Investing Activities. Cash used in investing activities for the three months ended March 31, 2013 was $(100,000) as compared to $0 for the three months ended March 31, 2012.

Cash Provided by/(Used in) Financing Activities. Our cash provided by financing activities for the three months ended March 31, 2013 was $0 as compared to cash provided by financing activities of $0 for the three months ended March 31, 2012. While no assurances can be given, we remain cash flow positive have not needed to seek or secure additional working capital to operate and grow the business since the fourth quarter of 2010.

WHERE YOU CAN FIND MORE INFORMATION

You are advised to read this Quarterly Report on Form 10-Q in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Report on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

Market risk

As filed, 1,411 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business is currently conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although if the geographical scope of our business broadens, we may do so in the future.

Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash equivalents consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change.

We do not hold any derivative instruments and do not engage in any hedging activities.

Controls and procedures

As filed, 3,984 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures were designed to provide reasonable assurance that the controls and procedures would meet their objectives. As required by SEC Rule 13a-15(b), our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining adequate internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, management has conducted an assessment, including testing, using the criteria in Internal Control — Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management has used the framework set forth in the report entitled Internal Control-Integrated Framework published by the COSO to evaluate the effectiveness of our internal control over financial reporting. Based on this assessment, our Chief Executive Officer and Chief Financial Officer have concluded that our internal control over financial reporting was effective as of March 31, 2013. This Quarterly Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Our internal control over financial reporting was not subject to attestation by our independent registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this Quarterly Report. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

(b) Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal controls over financial reporting or in other factors that could materially affect, or are reasonably likely to affect, our internal controls over financial reporting during the quarter ended March 31, 2013. There have not been any significant changes in the Company's critical accounting policies identified since the Company filed its Annual Report on Form 10-K as of December 31, 2012.

PART II

OTHER INFORMATION

Risk factors

As filed, 211 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There are no risk factors identified by the Company in addition to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2012.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-01-01 to 2013-03-31$6.1mus-gaap:Revenues
Cost of revenue3 months2013-01-01 to 2013-03-31$3.8mus-gaap:CostOfGoodsSold
Gross profit3 months2013-01-01 to 2013-03-31$2.3mus-gaap:GrossProfit
Operating income3 months2013-01-01 to 2013-03-31$603.3kus-gaap:OperatingIncomeLoss
Interest expense3 months2013-01-01 to 2013-03-31$4.4kus-gaap:InterestExpense
Income tax3 months2013-01-01 to 2013-03-31$11.5kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-01-01 to 2013-03-31$587.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-01-01 to 2013-03-31$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-01-01 to 2013-03-31$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-01-01 to 2013-03-3190,110,733 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2013-01-01 to 2013-03-31−$127.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-03-31$709.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-03-31$6.9mus-gaap:AssetsCurrent
Total assetsAt period end2013-03-31$8.2mus-gaap:Assets
Current liabilitiesAt period end2013-03-31$1.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-03-31$1.5mus-gaap:Liabilities
Shareholders' equityAt period end2013-03-31$6.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001415889-13-000964. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.